Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19

BACKGROUND AND AIMS: Low-density lipoprotein (LDL) plasma concentration decline is a biomarker for acute inflammatory diseases, including coronavirus disease-2019 (COVID-19). Phenotypic changes in LDL during COVID-19 may be equally related to adverse clinical outcomes. METHODS: Individuals hospitali...

Descripción completa

Detalles Bibliográficos
Autores principales: Carmo, Helison Rafael P., Yoshinaga, Marcos Y., Castillo, Alejandro Rosell, Britto Chaves-Filho, Adriano, Bonilha, Isabella, Barreto, Joaquim, Muraro, Stéfanie Primon, de Souza, Gabriela Fabiano, Davanzo, Gustavo Gastão, Perroud, Maurício W., Lukhna, Kishal, Ntsekhe, Mpiko, Davidson, Sean, Velloso, Licio A., Nadruz, Wilson, Carvalho, Luiz Sérgio F., Sáinz-Jaspeado, Miguel, Farias, Alessandro S., Proença-Módena, José Luiz, Moraes-Vieira, Pedro M., Karathanasis, Sotirios K., Yellon, Derek, Miyamoto, Sayuri, Remaley, Alan T., Sposito, Andrei C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969752/
https://www.ncbi.nlm.nih.gov/pubmed/36889041
http://dx.doi.org/10.1016/j.ymgme.2023.107552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969752/
https://www.ncbi.nlm.nih.gov/pubmed/36889041
http://dx.doi.org/10.1016/j.ymgme.2023.107552

Ejemplares similares